Zweig Logo  PUBLICATIONS
Resulting from Zweig-Funded Research

Hard Rule

Zweig Home | History | Committee | Current Projects | Archive | Publications | Links

View by:

Category

Year

Zweig-Funded Principal Investigator

  

    Ainsworth, Dorothy M.

  1. Outcome of horses diagnosed with and treated for heaves (abstract).
    Ainsworth DM, Eicker SW. 1998. Proc World Equine Airways Symp. 1:17.
  2. Effects of pulmonary abscesses on racing performance of horses treated at referral veterinary medical teaching hospitals: 45 cases (1985-1997).
    Ainsworth DM, Erb HN, Eicker SW, Yeager AE, Viel L, Sweeney CR, Lavoie JP. 2000. JAVMA. 216(8):1282-1287.
  3. Outcome of horses diagnosed with and treated for heaves (recurrent airway obstruction).
    Aviza GA, Ainsworth DM, Eicker SW, Santiago MA, Divers TJ, Perkins GA. 2001. Equine Veterinary Education. 13(5):243-246.
  4. IgG antibody responses to an inhaled antigen in horses with "heaves" (recurrent airway obstruction).
    Ainsworth DM, Appleton JA, Antczak DF, Santiago MA, Aviza G. 2002. Vet Immunol Immunopathol. Jan 15;84(3-4):169-80.
  5. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells.
    Ainsworth DM, Grunig G, Matychak MB, Young J, Wagner B, Erb HN, Antczak DF. 2003. Veterinary Immunology and Immunopathology. 96(1-2):83-91.
  6. The effect of strenuous exercise on mRNA concentrations of interleukin-12, interferon-gamma and interleukin-4 in equine pulmonary and peripheral blood mononuclear cells.
    Ainsworth DM, Appleton JA, Eicker SW, Luce R, Flaminio MJ, Antczak DF. 2003. Vet Immunol Immunopath. 91:61-71.

    7. Antczak, Douglas F.

  7. Invasive equine tropho-blast expresses conventional class I Major Histocompatibility Complex antigens.
    Donaldson WL, Zhang CH, Oriol JG, Antczak DF. 1990. Development . 110:63-71. This paper was awarded one of two national Phi Zeta prizes for papers submitted by post-graduate veterinary students in 1991.
  8. Xenogeneic donkey-in-horse pregnancy created by embryo transfer: immunological aspects of a model of early abortion.
    Allen WR, Kydd J, Antczak DF. 1990. Chapter 22 Immunology of the Fetus (G. Chaouat, ed.), CRC Press, Boca Raton, FL. pp 267-292.
  9. Molecules of the early equine trophoblast.
    Oriol JG, Donaldson WL, Dougherty DA, Antczak DF. 1991. J. Reprod. Fert. Suppl.. 44:455-462.
  10. Analysis of horse and donkey gonadotrophin genes using Southern blotting and DNA hybridization techniques.
    Stewart F, Maher J. 1991. J. Reprod. Fertil. Suppl.. 44:19-25. Articles published by members of the Equine Genetics Center laboratory sometimes do not include Dr. Antczak as an author, even if he was the principal investigator of the grant supporting that research. For those publications members of Dr. Antczak's laboratory are marked in bold face type.
  11. Characterization of BPV-like DNA in Equine Sarcoids.
    Angelos JA, Marti E, Lazary S, Carmichael LE. 1991. Archives of Virology. 119:95-109. Articles published by members of the Equine Genetics Center laboratory sometimes do not include Dr. Antczak as an author, even if he was the principal investigator of the grant supporting that research. For those publications members of Dr. Antczak's laboratory are marked in bold face type.
  12. Unusual selective immunoglobulin deficiency in an Arabian foal.
    Boy M, Zhang CH, Antczak DF, Hamir A, Whitlock R. 1992. J Vet Internal Med. 6:201-205.
  13. Differentiation of chronic lymphocytic leukemia in the horse: a report of two cases.
    Dascanio JJ, Zhang CH, Antczak DF, Blue JT, Simmons TR. 1992. J Vet Internal Med. 6:225-229.
  14. Selective IgM deficiency and abnormal B-cell response in a foal.
    Weldon AD, Zhang CH, Antczak DF, Rebhun WC. 1992. J Am Vet Med Assoc. 201:1396-1398.
  15. The Major Histocompatibility Complex of the Horse.
    Antczak DF. 1992. Equine Infectious Diseases VI, Proceedings of the Sixth International Conference, 7th-11th July, 1991, Cambridge UK (Plowright W, Rossdale PD, Wade JF, eds.), R&W Publications (Newmarket) Ltd. p. 99-112.
  16. Molecular cloning of equine CD44 cDNA by a COS cell expression system.
    Tavernor AS, Deverson EV, Coadwell WJ, Lunn DP, Zhang C, Davis W, Butcher GW. 1992. Immunogenetics. 37:474-477. Articles published by members of the Equine Genetics Center laboratory sometimes do not include Dr. Antczak as an author, even if he was the principal investigator of the grant supporting that research. For those publications members of Dr. Antczak's laboratory are marked in bold face type.
  17. Developmental regulation of class I Major Histocompatibility Complex antigen expression by equine trophoblastic cells.
    Donaldson WL, Oriol JG, Plavin A, Antczak DF. 1992. Differentiation. 52:69-78.
  18. Horse cDNA clones encoding two MHC class I genes.
    Barbis DP, Maher JK, Stanek J, Klaunberg BA, Antczak DF. 1994. Immunogenetics. 40: 163.
  19. An equine B cell surface antigen defined by a monoclonal antibody..
    Zhang CH, Donaldson WL, Antczak DF. 1994. Vet Immunol Immunopathol. 42:91-102.
  20. Variation in expression of MHC class II antigens on horse lymphocytes determined by MHC haplotype.
    Barbis DP, Bainbridge D, Crump AL, Zhang CH, Antczak DF. 1994. Vet Immunol Immunopathol. 42:103-114.
  21. Intravascular leukostasis and systemic aspergillosis in a horse with acute subleukemic myelomonocytic leukemia.
    Buechner-Maxwell V, Zhang C, Robertson J, Jain NC, Antczak DF, Feldman BF, Murray MJ. 1994. J Vet Int Med. 8:258-263.
  22. Down-regulation followed by re-expression of equine CD4 molecules in response to phorbol myristate acetate.
    Zhang CH, Grünig G, Davis W, Antczak DF. 1994. Vet Immunol Immunopathol. 42:71-82.
  23. MHC gene expression in placentas of domestic animals.
    Antczak DF, Maher JK, Grünig G, Donaldson WL , Kydd J, Allen WR. 1994. SERONO Symposium: Immunobiology of Reproduction (J.S. Hunt, ed.). pp. 153-169.
  24. Paternal and maternal Major Histocompatibility Complex class I antigens are expressed co-dominantly by equine trophoblast.
    Donaldson WL, Oriol JG, Pelkaus CL, Antczak DF. 1994. Placenta. 15:123-135.
  25. Molecular cloning and characterization of horse DQB cDNA.
    Szalai G, Antczak DF, Gerber H, Lazary S. 1994. Immunogenetics. 40:458.
  26. Molecular cloning and characterization of horse DQA cDNA.
    Szalai G, Antczak DF, Gerber H, Lazary S. 1994. Immunogenetics. 40:457.
  27. The complete cDNA and deduced amino acid sequence of equine IgE.
    Navarro P, Barbis DP, Antczak D, Butler JE. 1995. Molec Immunol. 32:1-8.
  28. Summary Report of the Second Equine Leucocyte Antigen Workshop.
    Lunn DP, Holmes MA, Antczak DF. 1996. Vet Immunol Immunopathol. 54:159-161.
  29. The equine homologue of LFA-1 (CD 11a/CD18): cellular distribution and differential determinants.
    Zhang CH, Davis WC, Grünig G, Antczak DF. 1998. Vet Immunol Immunopath. 62:167-183.
  30. Report of the Second Equine Leucocyte Antigen Workshop, Squaw Valley, California, July 1995.
    Lunn DP, Holmes MA, Antczak DF, et al.. 1998. Vet Immunol Immunopath. 62:101-143.
  31. Genome methylation in interspecific eutherian hybrids.
    Römer I, Grützner F, Winking H, Haaf T, Niveleau A, Orth A, Skidmore L, Antczak D, Fundele R. 1999. Nature. 401:131-132.
  32. Equine dinucleotide repeat loci COR081-COR100.
    Tallmadge R, Evans KG, Hopman TJ, Schug MD, Aquadro CF, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Anim. Genet.. 30(6):462-78.
  33. Equine dinucleotide repeat loci COR001-COR020.
    Hopman TJ, Han EB, Story MR, Schug MD, Aquadro C, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Anim. Genet. 30(3):225-6.
  34. Report of the International Equine Gene Mapping Workshop: Male Linkage Map.
    Guérin G, Bailey E, Bernoco D, Anderson I, Antczak DF, et al. 1999. Anim. Genet.. 30:341-354.
  35. Equine dinucleotide repeat loci COR041-COR060.
    Ruth LS, Hopman TJ, Schug MD, Aquadro CF, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Animal Genetics. 30:320.
  36. Equine dinucleotide repeat loci COR061-COR080.
    Tallmadge R, Hopman TJ, Schug MD, Aquadro CF, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Anim. Genet.. 30:462-463.
  37. Equine dinucleotide repeat loci COR021-COR040.
    Murphie AM, Hopman TJ, Schug, MD, Aquadro CF, Bowling AT, Murray JD, Caetano AR, Antczak DF. 1999. Anim. Genet.. 30(3):235.
  38. First comprehensive low-density horse linkage map based on two 3-generation, full-sibling, cross-bred horse reference families.
    Swinburne J, Gerstenberg C, Breen M, Aldridge V, Lockhart L, Marti E, Antczak D, Eggleston-Stott M, Bailey E, Michelson J, Røed K, Lindgren G, von Haeringen W, Guérin G, Bjarnason J, Allen T, Binns M. 2000. Genomics . 66:123-134.
  39. Equine trophoblast as an immunological target.
    Baker JM, Bamford AI, Carlson ML, McCullough CE, Antczak DF. 2000. Journal of Reproduction and Fertility. (Suppl 56:635-644.
  40. Reproduction and modern breeding technologies in the mare.
    Allen WR and Antczak DF. 2000. Chapter 12, The Genetics of the Horse (A.T. Bowling and A. Ruvinsky, eds.), CAB International, Oxon, U.K.. pp. 307-341.
  41. Immunogenetics of the horse.
    Bailey E, Marti E, Fraser DG, Antczak DF, Lazary S. 2000. Chapter 7, The Genetics of the Horse (A.T. Bowling and A. Ruvinsky, eds.), CAB International, Oxon, U.K., pp. 123-155..
  42. The gene jockeys of the horse genome project.
    Antczak DF. 2001. Proc. 19th Annual ACVIM Forum, Denver, CO. pp. 257-259.
  43. They're off and running—applications of equine genetic research.
    Antczak DF. 2001. Proc. 19th Annual ACVIM Forum, Denver, CO. pp. 260-262.
  44. PCR-based genotyping for the equine MHC class II locus DBQ—multiple alleles or multiple loci?.
    Bird H, Savidge C, Miller DC, Hopman T, Antczak DF. 2001. Plant and Animal Genome IX Conference, San Diego, Jan. 13-17. Abstract
  45. Natural killer cell receptors in the horse: evidence for the existence of multiple transcribed LY49 genes.
    Takahashi T, Yawata M, Raudsepp T, Lear TL, Chowdhary BP, Antczak DF, Kasahara M. 2003. Eur J Immunol. 34:773-784.
  46. The second generation of the International Equine Gene Mapping Workshop half-sibling linkage map.
    Guerin G, Bailey E, Bernoco D, Anderson I, Antczak DF, Bell K, Biros I, Bjornstad G, Bowlilng AT, Brandon R, Caetano AR, Cholewinski G, Colling D, Eggleston M, Ellis N, Flynn J, Gralak B, Hasegawa T, Ketchum M, Lindgren G, Lyons LA, Millon LV, Mariat D, Murray J, Neau A, Loed K, Sandberg K, Skow LC, Tammen I, Tozaki T, Van Dyk E, Weiss B, Young A, Ziegle J. 2003. Animal Genetics. 34(3):161-168.
  47. An Ordered BAC contig map of the equine Major Histocompatibility Complex.
    Gustafson AL, Tallmadge RL, Ramlachan N, Miller D, Bird H, Antczak DF, Raudsepp T, Chowdhary BP, Skow LC. 2003. Cytogenet Genome Res. 102:189-195.
  48. Genomic Applications to Equine Immunity (Booklet).
    Antczak, Douglas F. 2003. Havemeyer Foundation Workshop, June 2003, Ithaca, NY.
  49. Equine Gene Mapping Workshop.
    Antczak, Douglas F. 2003. Havemeyer Foundation, August 2003, Kruger Park, South Africa.
  50. Advances in equine immunology: Havemeyer workshop reports from Santa Fe, New Mexico, and Hortobagy, Hungary.
    Marti E, Horohov DW, Antczak DF, Lazary S, Lunn DP. 2003. Veterinary Immunology and Immunopathology. 91(3-4):233-243.
  51. The first generation whole genome radiation hybrid map in the horse identifies conserved segments in human and mouse genomes.
    Chowdhary BP, Raudsepp T, Sata SR, Goh G, Millon LV, Alan V, Piumi F, Guerin G, Swinburne J, Binns M, Michelson J, Murray J, Antczak DF, Womack JE, Skow LC. 2003. Genome Research. 13:742-751.
  52. Characterization of the b-2-microglobulin gene of the horse.
    Tallmadge RL, Lear TL, Johnson AK, Guerin G, Millon LV, Carpenter SL,Antczak DF. 2003. Immunogenetics. 54:725-733.

    53. Bedford-Guaus S

  53. A defined medium supports changes consistent.
    J, McPartlin LA, Littell J, Mark E, Nelson JL, Travis AJ. 2008. 15;69(5):639-50. Epub.

    54. Chang, Yung-Fu

  54. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer surface protein A (OspA) in horses.
    Chang Y-F, Novosol V, McDonough SP, Jacobsen RJ, Chang C-F, Divers T, Quimby FW, Shin S, Lein DH. 1999. Vaccine. 18:540-548.
  55. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
    Chang YF, Novosol V, McDonough SP, Chang CF, Jacobson RH, Divers TJ, Quimby FW, Shin S, Lein DH. 2000. Vaccine. 18(5-6):540-548.
  56. Experimental infection of ponies with Borrelia burgdorferi by exposure to Ixodid ticks.
    Chang Y-F, Novosol V, McDonough SP, Chang C-F, Jacobsen RJ , Divers T, Quimby FW, Shin S, Lei DH. 2000. Vet Pathol. 37:68-76.
  57. Human granulocytic ehrlichiosis agent (HGE) infection in a pony vaccinated with recombinant OspA vaccine and challenged by exposure to naturally infected ticks.
    Chang Y-F, McDonough SP, Shin K-S, Chang C-F, Divers T. 2000. Clin Diagn Immunol. 7:68-71.
  58. Polysaccharide storage myopathy in Morgan, Arabian, and Standardbred related horses and Welsh-cross ponies.
    Valentine BA, McDonough SP, Chang Y-F, Vonderchek AJ. 2000. Vet Pathol. 37:193-196.
  59. Cloning and Molecular Characterization of an Immunogenic LigA Protein of Leptospira interrogans.
    Palaniappan RUM, Chang YF, Jusuf SSD, Artiushin S, Timoney JF, McDonough SP, Barr SC, Divers TJ, Simpson KW, McDonough PL, Mohammed HO. 2002. Infection and Immunity. 70(11):5924-5930.
  60. Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA.
    Palaniappan RU, Chang YF, Hassan F, McDonough SP, Pough M, Barr SC, Simpson KW, Mohammed HO, Shin S, McDonough P, Zuerner RL, Au J, Roe B. 2004. J Med Microbiology. 53(Pt 10):975-984.
  61. Evaluation of lig-based conventional and real time PCR for the detection of Pathogenic leptospires.
    Palaniappan RU, Chang YF, Chang CF, Pan MJ, Yang CW, Harpending P, McDonough SP, Dubovi E, Divers T, Qu J, Roe B. 2005. Mol Cell Probes. 19(2):111-117.
  62. Antibiotic treatment of experimentally Borrelia burgforferi-infected ponies.
    Chang YF, Ku YW, Chang CF, Chang CD, McDonough SP, Divers T, Pough M, Torres A. 2005. Veterinary Microbiology. 107:285-294.
  63. Immunoprotection of recombinant leptospiral immunoglobulin like A protein (LigA) against Leptospira interrogans serovar Pomona infection.
    Raghavan PUM, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, Chang YF. 2006. Infectious Immunology. 74:1745-1750.
  64. In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin.
    Kim D, Kordick D, Divers T, Chang YF. 2006. J Vet Sci. 7(4):355-359.
  65. A domain of the Leptospira LigB contributes to high affinity binding of fibronectin.
    Lin YP,Chang YF. 2007. Biochemical and Biophysical Research Communications. 362:443-448.
  66. Leptospirosis: pathogenesis, immunity, and diagnosis.
    Palaniappan RUM, Ramanujam S, Chang YF. 2007. Current Opinion in Infectious Diseases. 20:284-292.
  67. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates.
    Chang YF, Chen CS, Palaniappan RUM, He H, McDonough SP, Barr SC, Yan W, Faisal SM, Pan MJ, Chang CF. 2007. Vaccine. 25:8190-8197.
  68. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters.
    Faisal SM, Yan W, Chen CS, Palaniappan RUM, He H, McDonough SP, Chang YF. 2007. Vaccine. 26:277-287.
  69. Calcium binds to leptospiral immunoglobulin-like protein, LigB and modulates fibronectin-binding..
    Lin, Y.P., Raman, R., Sharma, Y., and Chang, Y.F. 2008. J. Biol. Chem. 283:25140-25149.
  70. The C-Terminal Variable Domain of LigB from Leptospira Mediates Binding to Fibronectin.
    Lin YP, Chang YF. 2008. J. Vet. Sci. 9(2), 133-144.

    71. Divers, Thomas J.

  71. Lyme disease in horses.
    Divers TJ, Chang YF, Jacobson RH, McDonough SP. 2001. Compendium on Continuing Education for the Practicing Veterinarian. 23(4):375-381.
  72. Prevention and treatment of thrombosis, phlebitis, and laminitis in horses with gastrointestinal diseases.
    Divers TJ. 2003. Veterinary Clinics of North America: Equine Practice. 19(3):779-790.
  73. Urinary and hepatic disorders in neonatal foals.
    Divers, TJ, Perkins, G. 2003. Clinical Techniques in Equine Practice. 2(1):67-78.
  74. Lyme disease.
    Divers, Thomas J. 2003. Chapter 2.7, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 54-56.
  75. Spinal coard diseases causing paresis and atrophy in the limbs.
    Divers, Thomas J. 2003. Chapter 14.4, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 750-753.
  76. Thoracolumbar spinal cord disorders causing upper motor neuron signs in the hindlimbs.
    Perkins GA, Divers TJ. 2003. Chapter 14.5, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 753-755.
  77. Complication of partial stylohyoidectomy for treatment of temporohyoid osteoarthropathy and an alternative surgical technique in three cases.
    Pease AP, van Biervliet J, Dykes NL, Divers TJ, Ducharme NG. 2004. Equine Veterinary Journal. 36(6):546-550.
  78. Evaluation of decision criteria for detection of spinal cord compression based on cervical myelography in horses: 38 cases (1981-2001).
    van Biervliet J, Scrivani PV, Divers TJ, Erb HN, deLahunta A, Nixon AJ. 2004. Equine Veterinary Journal. 36(1):14-20.
  79. Extradural undifferentiated sarcoma causing spinal cord compression in 2 horses.
    van Biervliet J, Alcaraz A, Jackson CA, Njaa B, deLahunta A, Divers TJ. 2004. Journal of Veterinary Medicine. 18(2):248-251.

    80. Ducharme, Normand G.

  80. An in vitro comparison of cordopexy, cordopexy and laryngoplasty, and laryngopolasty for treatment of equine laryngeal hemiplegia.
    Jansson N, Ducharme NG, Hackett RP, Mohammed HO. 2000. Veterinary Surgery. 29(4):326-334.
  81. Sound signature for identification and quantification of upper airway disease in horses.
    Cable CS, Ducharme NG, Hackett RP, Erb HN, Mitchell LM, Soderholm VL. 2002. AJVR. 63:12.
  82. Do thoroughbred and standardbred horses have similar increases in pulmonary vascular pressures during exertion?.
    Hackett RP, Ducharme NG, Gleed RD, Mitchell L, Soderholm LV, Erickson BK, Erb HN. 2003. Canadian Journal of Veterinary Research. 67(4):291-296.
  83. Investigations into the role of the thyrohyoid muscles in the pathogenesis of dorsal displacement of the soft palate in horses.
    Ducharme NG, Hackett RP, Woodie JB, Dykes N, Erb HN. 2003. Equine Veterinary Journal. 35(3):258-263.
  84. Can an external device prevent dorsal displacement of the soft palate during strenuous exercise?.
    Woodie JB, Ducharme NG, Hackett RP, Erb HN, Mitchell LM, Soderholm LV. 2005. Equine Vet J. 7(4):355-359.

    85. Ducharme, Normand G. and Ainsworth, Dorothy M.

  85. Effects of extrathoracic airway obstruction on intrathoracic pressure and pulmonary artery pressure in exercising horses.
    Hackett RP, Ducharme NG, Ainsworth DM, Erickson BK, Erb HN, Soderholm LV Jr, Thorson LM. 1999. Am J Vet Res. 60(4):485-94.

    86. Flaminio, Julia

  86. Serum IgM concentrations in normal, fit horses and horses with lymphoma or other medical conditions.
    Perkins GA, Nydam DV, Flaminio MJBF, Ainsworth DM. 2003. Journal of Veterinary Internal Medicine. 17(3):337-342.
  87. Immunomodulators in respiratory disease treatment.
    Flaminio, MJBF. 2003. Chapter 8.11, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 445-449.
  88. The proliferation inhibitory proteins p27(Kip1) and retinoblastoma involved in the control of equine lymphocyte proliferation.
    Flaminio MJBF, Yen A, Antczak DF. 2004. Veterinary Immunology and Immunopathology. 102(4):363-377.
  89. Inhibition of lymphocyte proliferation and activation: a mechanism used by equine invasive trophoblast to escape the maternal immune response.
    Flaminio MJBF, Antczak DF. 2005. Placenta. 26(2-3):148-159.
  90. The effect of CpG-ODN on antigen presenting cells of the foal.
    Flaminio MJBF, Borges AS, Nydam DV, Horohov DW, Hecker R, Matychak MB. 2007. Journal of Immune Based Therapies and Vaccines. 5:1-17.
  91. The effect of CpG-ODN on antigen presenting cells of the foal.
    Flaminio MJBF, Borges AS, Nydam DV, Horohov DW, Hecker R, Mattychak MB. 2007. Journal of Immune Based Therapies and Vaccines. 1:1-17.

    92. Flaminio, MJ

  92. Foal Monocyte-Derived Dendritic Cells Become Activated Upon Rhodoccoccus equi Infection..
    Nydam DV, Marquis H, Matychak, MB, Giguere S.. 2008. 16(2):176-83-Epub.

    93. Fortier, Lisa A.

  93. Mitogenesis and Chondrocytic Differentiation of Mesenchymal Cells Exposed to Transforming Growth Factor-B.
    Wooster AA, Nixon AJ, Fortier LA, Toland B, Williams J. 1997. Vet Surg. 26:434-435.
  94. Isolation and Chondrocytic Differentiation of Equine Bone-Marrow-Derived Mesenchymal Stem Cells.
    Fortier LA, Nixon AJ, Williams J, Cable CS. 1998. Am J Vet Res. 59:1182-1187.
  95. Disparate Chondrocyte Metabolism in Three-Dimensional Fibrin Cultures Derived from Autogenous or Commercially Manufactored Fibrinogen.
    Fortier LA, Brofman PJ, Nixon AJ, Mohammed HO. 1998. Am J Vet Res. 59:514-520.
  96. Insulin-Like Growth Factor-I Gene Expression Patterns During spontaneous Repair of Acute Articular Cartilage Injury.
    Fortier LA, Balkman CE, Sandell LJ, Radcliffe A, Nixon AJ. 2001. J Orthop Res. 19:720-728.
  97. Insulin-Like Growth Factor-I Enhances Cell-Based Repair of Articular Cartilage.
    Fortier LA, Mohammed HO, Lust G, Nixon AJ. 2002. J Bone Joint Surg Br. 84:276-288.
  98. Phenotypic Expression of Equine Articular Chondrocytes Grown in Three-Dimensional Cultures Supplemented with Suprapphysiologic Concentrations of Insulin-Like Growth Factor-I.
    Fortier LA, Nixon AJ, Lust G. 2002. Am J Vet Res. 63:301-305.
  99. Additional intraarticular therapies.
    Fortier, Lisa A. 2003. Chapter 10.16, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 555-557.
  100. Age-related changes in serum insulin-like growth factor-I, insulin-like growth factor-I binging protein-3 and articular cartilage structure in Thoroughbred horses..
    Fortier LA, Kornatowski MA, Mohammed HO, Jordan MT, O'Cain LC, Stevens WB. 2005. Equine Veterinary Journal. 37(1):37-42.
  101. Stem Cells: Classifications, Controversies and Clinical Applications.
    Fortier LA. 2005. Vet Surg. 34:415-423.
  102. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons.
    Schnabel LV, Mohammed HO, Miller BJ, McDermot WG, Jacobson MS, Santangelo KS, Fortier LA. 2007. J Ortho Research. 25:230-240.

    103. Gilmour, Robert F., Jr.

  103. The potential for acquired long QT syndrome (LQTS) in horses.
    Finley MR, Lillich J, Mitchell KE, Freeman LC, Gilmour RF. 2000. J Veterinary Internal Medicine. 14:355. Abstract
  104. Expression and co-association of ERG1, KCNQ1 and KCNE1 potassium channel proteins in horse heart.
    Finley MR, Lillich J, Li Y, Mitchell KE, Hua F, Gilmour RF, Freeman LC. 2002. Am J Physiol Heart Circ Physiol. 283(1):H126-38.
  105. Structural and functional basis for the long QT syndrome: relevance to veterinary patients.
    Finley M, Lillich J, Gilmour RF Jr., Freeman LC. 2003. Journal of Veterinary Internal Medicine. 17:473-488.

    106. Haussler, Kevin K.

  106. Complementary therapies for the treatment of musculoskeletal disorders.
    Haussler, Kevin K. 2003. Chapter 10.19, Current Therapy in Equine Medicine 5 (N.E. Robinson ed.). Saunders, St. Louis, pp. 567-571.
  107. Development and validation of a periarticular injection technique of the sacroilliac joint in horses.
    Engeli E, Haussler KK, Erb HN. 2004. Equine Veterinary Journal. 36(4):324-330.

    108. Houpt, Katherine

  108. Water and salt balance in exercising horses.
    Kleps, NA, Houpt, KA, Calabria-Maher, V. 1992. The Equine Athlete. 5:5-11.
  109. Formation and dissolution of the mare-foal bond.
    Houpt, KA. 2002. Applied Animal Behavior Science. 78:319-328.

    110. Nixon, Alan J.

  110. Use of IGF-I somatic gene therapy in the treatment of osteoarthritis.
    Nixon AJ, Brower-Toland BD, Robbins P, Evans CH. 1998. Proc, International Meeting, Gene Therapy Approaches to Arthritic and Allied Conditions. NIH. p 17.
  111. Cartilage repair using genetically modified chondrocytes secreting increased IGF-I ligand levels.
    Nixon AJ, Brower-Toland BD, Saxer RA, Goodrich LR, Robbins PD, Evans CH. 2000. Vet Surg. 29:471.
  112. Elevated synovial IGF-I following adenoviral IGF-I transgene delivery for equine joint disease.
    Goodrich LR, Nixon AJ, Brower-Toland BD, Bent SJ, Robbins PD, Evans CH. 2000. Vet Surg. 29:463.
  113. Growth factor gene induced cartilage repair.
    Nixon AJ, Bent SJ, Saxer RA, Brower-Toland BD, Evans CH. 2000. Proceedings, International Cartilage Repair Society, 3rd International Symposium. May.
  114. Direct adenovirus-mediated IGF-I gene transfer enhances transplant chondrocyte function.
    Nixon AJ, Brower-Toland BD, Robbins PD, Evans CH. 2000. Proceedings, International Cartilage Repair Society, 3rd International Symposium. p20.
  115. Articular IGF-I therapy via adenoviral recruitment of the synovial lining.
    Bent SJ, Saxer RA, Brower-Toland BD, Robbins PD, Evans CH, Nixon AJ. 2000. Trans, 46th Annual Meeting, Orthopaedic Research Society. 25:230.
  116. Insulin-like growth factor-I gene therapy applications in cartilage repair and degenerative joint diseases.
    Nixon AJ, Brower-Toland BD, Bent SJ, Saxer RA, Wilke MJ, Robbins PD, Evans CH. 2000. Clin Orthop Related Res. 379S:S201-S213.
  117. Delivery of biologically effective steady-state concentrations of IGF-I to cultured chondrocytes by adenoviral gene therapy.
    Brower-Toland BD, Saxer RA, Robbins PD, Evans CH, Nixon AJ. 2000. Trans, 46th Annual Meeting, Orthopaedic Research Society. 25:1064.
  118. Enhanced healing of articular cartilage defects with genetically engineered chondrocytes expressing bone morphogenetic protein-7.
    Hidaka C, Goodrich LR, Quitoriano M, Brower-Toland BD, Bent SJ, McCarthy D, Attia E, Warren RF, Crystal RG, Nixon AJ. 2000. Japanese Society of Clinical Biomechanics. Annual Meeting.
  119. Enhanced articular cartilage repair in the horse using chondrocytes transduced with an adenovirus-BMP7 transgene.
    Goodrich LR, Nixon AJ, Hidaka C, Quitoriano M, Brower-Toland BD, Bent SJ, Warren RG, Crystal RG. 2000. Vet Surg. 29:463.
  120. Direct in vivo adenoviral IGF-I transgene injection results in significant elevations of synovial IGF-I.
    Goodrich LR, Bent SJ, Brower-Toland BD, Robbins PD, Evans CH, Nixon AJ. 2001. Trans, 47th Annual Meeting, Orthopaedic Research Society. 26:283.
  121. Gene mediated insulin-like growth factor-I delivery to the synovium .
    Saxer RA, Bent SJ, Brower-Toland BD, Mi Z, Robbins PD, Evans CH, Nixon AJ. 2001. J Orthop Res. 19(5):759-67.
  122. Intraarticular injection of adenoviral IGF-I transgene results in significant elevations of synovial IGF-I.
    Goodrich LR, Bent SJ, Brower-Toland BD, Robbins PD, Evans CH, Nixon AJ. 2001. Molecular Therapy. 3:S390.
  123. Gene mediated control of cartilage degradation by combination IGF-I/IL-1 receptor antagonist therapy.
    Nixon AJ, Haupt JL, Frisbie DD, Morisett SS, Robbins PD, Ghivizzani S, Evans CH, McIlwraith CW. 2001. Vet Surg. 30:294.
  124. Direct adenovirus-mediated insulin-like growth factor-I gene transfer enhances transplant chondrocyte function.
    Brower-Toland BD, Saxer RA, Goodrich LR, Mi Z, Robbins PD, Evans CH, Nixon AJ. 2001. Human Gene Therapy. 12:117-129.
  125. Accelerated cartilage defect healing in horses by implantation of genetically modified chondrocytes expressing bone morphogenetic protein-7.
    Hidaka C, Goodrich LR, Quitoriano M, Bent SJ, Brower-Toland BD, Crystal RG, Nixon AJ. 2001. Trans, 47th Annual Meeting, Orthopaedic Research Society. 26:157.
  126. Cartilage repair using genetically modified chondrocytes secreting increased IGF-I ligand levels.
    Nixon AJ, Brower-Toland BD, Robbins PD, Evans CH. 2001. Molecular Therapy. 3:S284.
  127. Arthroscopic surgery of the carpal and digital tendon sheaths.
    Nixon, Alan J. 2003. Clinical Techniques in Equine Practice. 1(4):245-256.
  128. Arthroscopic techniques for cartilage repair.
    Nixon, Alan J. 2003. Clinical Techniques in Equine Practice. 1(4):257-269.
  129. Radiographic and pathologic characterization of lateral palmar intercarpal ligament avulsion fractures in the horse.
    Beinlich CP, Nixon AJ. 2004. Veterinary Radiology and Ultrasound. 45(6):532-537.
  130. Expression of bone morphogenetic protein-6 and -2 and a bone morphogenetic protein antagonist in horses with naturally acquired osteochondrosis.
    Semevolos SA, Nixon AJ, Strassheim ML. 2004. American Journal of Veterinary Research. 65(1):110-115.
  131. Exostoses of the caudal perimeter of the radial physis as a cause of carpal synovial sheath tenosynovitis and lameness in horses: 10 cases (1999-2003).
    Nixon AJ, Schachter BL, Pool RR. 2004. Journal of the American Veterinary Medical Association. 224(2):264-270.
  132. Arthroscopic reattachment of osteochondritis dissecans lesions using resorbable polydioxanone pins.
    Nixon AJ, Fortier LA, Goodrich LR, Ducharme NG. 2004. Equine Veterinary Journal. 36(5):376-383.
  133. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model.
    Goodrich LR, Hidaka C, Robbins PD, Evans CH, Nixon AJ. 2007. The Journal of Bone and Joint Surgery. 89-B(5):672-685.

    134. Osterrieder N

  134. Equine herpesvirus type 1 (EHV-1) entry via endocytosis is facilitated by aV ....
    Van de Walle, ED, Peters GR, Van der Ven BC, O'Callaghan, DJ N.. 2008. J Virol. [Epub ahead of print].
  135. Detection of Equine Herpesvirus-1 in Nasal Swabs of Horses by Quantitative Real-Time PCR.
    Perkins GA, Goodman LB, Dubovi EJ, Kim SG. 2008. Journal of Veterinary Internal Medicine. 08/05 [Epub ahead of print].
  136. Analysis of the herpesvirus chemokine-binding glycoprotein G residues essential for chemokine ....
    Van de Walle, GR, Kaufer BB, Chbab N. 2008. J Biol Chem. [Epub ahead of print.
  137. Alphaherpesviruses and Chemokines: pas de deux not yet brought to perfection.
    Van de Walle, GR, Jarosinski, KW. 2008. J. Virol. 82,6090-6092.
  138. Equine Herpesvirus Type 1 (EHV-1) based experimental vaccine.
    Rosas, C.T., Paessler, S, Ni, H.. 2008. Am J Trop Med Hyg. 8, 83-92.
  139. Varicellovirus UL 49.5 Proteins Differentially affect the Function of the Transporter ....
    Koppers-Lalic D, Verweij MC, Lipiska AD, Wang Y, . 2008. t PloS Pathogens. 05/30;4(5):e1000080.

    140. Osterrieder, Nikolaus

  140. Generation and characterization of an EICPO null mutant of equine herpesvirus 1.
    Yao H, Osterrieder N, O'Callaghan DJ. 2003. Virus Research. 98(2):163-172.
  141. Cytokine profiles and long-term visur-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D.
    Zhang Y, Smith PM, Frampton AR, Osterrieder N, Jennings SR, O'Callaghan DJ. 2003. Viral Immunology. 16(3):307-320.
  142. Equine herpesvirus type 1 (EHV-1) glycoprotein K is required for efficient cell-to-cell spread and virus egress.
    Neubauer A, Osterrieder N. 2004. Virology. 329(1):18-32.
  143. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain Kya is not functionally equivalent to full-length pg2 encoded by EHV-1 wild-type strainRacL11.
    von Elinem J, Wellington J, Whalley JM, Osterrieder K, O'Callaghan DJ, Osterrieder N. 2004. Journal of Virology. 78(6):3003-3013.
  144. Meningoencephalitis in mice infected with an equine herpesvirus 1 strain KyA recombinant expressing glycoprotein I and glycoprotein E..
    Frampton Ar Jr, Smith PM, Zhang Y, Grafton WD, Matsumura T, Osterrieder N, O'Callaghan DJ. 2004. Virus Genes. 29(1):9-17.
  145. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1)completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.
    Smith PM, Sahan SM, Rorex CB, von Einen J, Osterrieder N, O'Callaghan DJ. 2005. Journal of Virology. 79(8):5105-15.
  146. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.
    Frampton Ar Jr, Goins WF, Cohen JB, von Einen J, Osterrieder N, O'Callaghan DJ, Glorioso JC. 2005. Journal of Virology. 79(5):3169-73.
  147. Potential of equine herpesvirus 1 as a vector for immunization.
    Trapp S, von Einem J, Hoffmann H, Kostler J, Wild J, Wagner R, Beer M, Osterrieder N. 2005. Journal of Virology. 79(9):5445-54.
  148. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KL, Metzgar SM, Holland R, Osterrieder N. 2006. Vaccine. Apr 24; 24(17):363-45.
  149. The alpha-TIF (VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary envelopment and virus egress.
    von Einem J, Schumacher D, O'Callaghan DJ, Osterrieder N. 2006. J Virol. Mar; 80(6):2609-20.
  150. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?.
    Ross CT, Goodman LB, von Einem J, Osterrieder N. 2006. Expert Rev Vaccines. Feb; 5(1):119-31.
  151. Marek's disease virus: from miasma to model.
    Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S. 2006. Nat Rev Microbiol. Apr;4(4):283-94.
  152. Report of the equine herpesvirus-1 Havermeyer Workshop, San Gimignano, Tuscany, June 2004.
    Slater JD, Lunn DP, Horohov DW, Antczak DF, Babiuk L, Breathnach C, Chang YW, Davis-Poynter N, Edington N, Ellis S, Foote C, Goehring L, Kohn CW, Kydd J, Matsumura T, Minke J, Morley P, Mumford J, Neubauer T, O'Callaghan D, Osterrieder K, Reed S, Smith K, Townsend H, van der Meulen K, Whalley M, Wilson WD. 2006. Vet. Immunol Immunopathol. 2006 May 15; 111(1-2);3-13.
  153. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli.
    Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Biotechniques. Feb; 40(2):191-7.
  154. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MF, Sussman KH, Metzger SM, Holland R, Osterrieder N. 2006. Vaccine. In press.
  155. The a-TIF (VP16) homologue (ETIF) of equine herpesvirus type 1 (EHV-1) is essential for secondary envelopment and virus egress.
    von Einem J, Schumacher D, O'Callaghan DJ, Osterrieder N. 2006. Journal of Virology. 80(6) In Press.
  156. Two-step Red-mediated recombination for versatile, high-efficiency markerless DNA manipulation in Escherichia coli.
    Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. BioTechniques. 40(2):191-197.
  157. Modified live vaccines against infections with equine herpesvirus type 1 (EHV-1) - Quo vaditis?.
    Rosas C, Goodman LB, von Einem J, Osterrieder N. 2006. Expert Review of Vaccines. 5(1):119-31.
  158. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).
    von Einem J, Smith PM, Van de Walle GR, O'callaghan DJ, Osterrieder N. 2007. Virology. January 22; [Epub ahead of print].
  159. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Ross CT, Tischer BK, Perkins GA, Wagner B, Goodman LB, Osterrieder N. 2007. Virus. January 20; [Epub ahead of print].

    160. Rassnick, Kenneth

  160. Cyclooxygenase-2 immunoreactivity in equine ocular squamous cell carcinoma.
    Rassnick KM, Njaa BL. 2007. J Vet Diag Investigation. 19(4): in press.

    161. Rawlinson J

  161. Image-guided Tissue Engineering of Anatomically Shaped Implants via MRI and Micro-CT ....
    Ballyns, J, Gleghorn J, Niebrzydowski V, Potter, H, Maher S, Wright T, Bonassar L.. 2008. Tissue Engineering Part A.. 14(7):1195-1202.

    162. Volkmann, Dietrich H.

  162. Leukocytes trapped in the fetal membranes of newborn foals.
    Volkmann DH, Gilbert RO, Gradil C, and Linke R. 2002. Proceedings of the 8th International Symposium on Equine Reproduction. Published as Evans MJ (Ed), Equine Reproduction VII. Special Issue Theriogenology:787-790.
  163. The use of hormone profiles in the study of the pathogenesis of the mare Reproductive Loss Syndrome.
    Volkmann DH, Zent W, Riddle WT, Little TV, Durenberger J, Potenze K, Sibley L, Roser JF. 2005. Theriogenology. Submitted.

    164. Wagner B

  164. Monoclonal antibodies to equine interferon-a (IFN-a ): New tools to neutralize IFN-activity ....
    Hillegas M, Flaminio J, Wattrang E.. 2008. Epub. 15;125(3-4):315-25..

    165. Wagner, Bettina

  165. Characterization of the horse (Equus caballus) IGHA gene.
    Wagner B, Greiser-Wilke I, Antczak DF. 2003. Immunogenetics. 55:552-560.
  166. Monoclonal anti-equine IgE antibodies with specificity for different epitopes on the immunoglobulin heavy chain of native IgE.
    Wagner B, Radbruch A, Rohwer J, Leibold W. 2003. Veterinary Immunology and Immunopathology. 92(1-2):45-60.
  167. The complete map of the Ig heavy chain constant gene region reveals evidence for seven IgG Isotypes and for IgD in the horse.
    Wagner B, Miller DC, Lear TL, Antczak DF. 2004. J Immunol. 173:230-3242.
  168. Horse cytokine/IgG1 fusion proteins mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B, Robeson J, McCracken M, Wattrang E, Antczak DF. 2005. Vet. Immunol. Immunopathol. 105:1-14.
  169. A monoclonal antibody to equine interleukin 4.
    Wagner B, Hillegas JM, Antczak DF. 2006. Vet. Immunol. Immunopathol. 110:363-367.
  170. IgE and IgG antibodies in skin allergy of the horse.
    Wagner B, Miller WH, Morgan EE, Hillegas JM, Erb HN, Leibold W, Antczak DF. 2006. Vet. Res. 37:813-825.
  171. Occurrence of IgE in foals: evidence of transfer of maternal IgE by the colostrum and late onset of endogenous IgE production in the horse.
    Wagner B, Flaminio JBF, Hillegas J, Leibold W, Erb HN, Antczak DF. 2006. Vet. Immunol. Immunopathol. 110:269-278.
To top of page


Zweig Home | History | Committee | Current Projects | Archive | Publications | Links

Cornell University College of Veterinary Medicine
 Questions or Comments?
Last Revised on April 27, 2009